$MRK Company News Merck, J.P. Morgan lead Dow decliners

New Post Public Reply Private Reply Replies (0) Message Board

Dec 1, 2013 at 1:17 PM

$MRK Company News

Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Everything you need to know about buying Bitcoins 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 profit falls to $1.12 bln vs. $1.73 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 EPS falls to $0.38 from $0.56 year ago 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan

Losing Some Sparkle to Buybacks 3:10 a.m. Nov. 30, 2013 - Barrons.com
Merck's Noxafil Tablets Approved by the FDA - Analyst Blog 11:30 a.m. Nov. 29, 2013 - Zacks.com
Buy Today: Merck & Co Inc's Buy Recommendation Reiterated 9:00 a.m. Nov. 29, 2013 - TheStreet.com
Drug Stocks: Winners, Losers, in Statin Shift 10:41 p.m. Nov. 27, 2013 - Barrons.com
Updated statin guidelines give AstraZeneca the upper hand: Barron's 10:54 a.m. Nov. 27, 2013 - Seeking Alpha
GlaxoSmithKline: What's The Next Growth Driver? 2:38 p.m. Nov. 26, 2013 - Seeking Alpha
Dow Today: Merck (MRK) Lower 12:16 p.m. Nov. 26, 2013 - TheStreet.com
Cramer's Mad Money - First Solar's Day In The Sun (11/25/13) 5:54 a.m. Nov. 26, 2013 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: A Glass-Half-Full Market 8:25 p.m. Nov. 25, 2013 - TheStreet.com
Can Pfizer Continue to Outperform? 5:29 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Disney’s Pixar Studios Lays Off Workers Following ‘The Good Dinosaur’ Delay 1:17 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
$112 Billion Fund Down On Stocks: Except These 12:05 p.m. Nov. 25, 2013 - Seeking Alpha
5 Drugs Stocks Moving The Industry Upward 12:03 p.m. Nov. 25, 2013 - TheStreet.com
Stock Market News for November 25, 2013 - Market News 10:06 a.m. Nov. 25, 2013 - Zacks.com
Achillion Pharmaceuticals: 3 Different Insiders Have Purchased Shares This Month 8:59 a.m. Nov. 25, 2013 - Seeking Alpha
Recent Cloud IPO Veeva Systems Scores In Health Biz 3:31 p.m. Nov. 22, 2013 - Investors Business Daily
Watch For Today's Momo Momentum Stock: Merck (MRK) 12:05 p.m. Nov. 22, 2013 - TheStreet.com
Dow Today: Merck (MRK) Higher 12:00 p.m. Nov. 22, 2013 - TheStreet.com
Gilead Hepatitis C Drug Wins EU Panel Vote Early 10:28 a.m. Nov. 22, 2013 - Investors Business Daily
Merck & Co Inc (MRK): Today's Featured Drugs Winner 5:00 p.m. Nov. 21, 2013 - TheStreet.com

FDA Approvals, Stock Price Updates, New Study Results, Conference Schedules and Partnerships - Research Report on Merck, Pharmacyclics, UnitedHealth Group, Medtronic, and AstraZeneca 8:00 a.m. Nov. 29, 2013 - PR Newswire
Merck Announces Increased Quarterly Dividend 2:18 p.m. Nov. 26, 2013 - BusinessWire
FDA Approves Merck's NOXAFIL(R) (posaconazole) Delayed-Release Tablets 9:00 a.m. Nov. 26, 2013 - BusinessWire
Stock Price Movements and Program Launches Reported by Healthcare Companies - Research Report on Merck, Abiomed, Alere, Raptor Pharmaceuticals and West Pharmaceutical Services 8:00 a.m. Nov. 26, 2013 - PR Newswire
SiSense Wins Quarter Million Dollar Prize, Takes Top Honor in "Take the H.E.L.M." Competition 11:30 a.m. Nov. 25, 2013 - PR Newswire
Mondo Guerra and the Merck HIV Educational Campaign I Design Invite the Community to Pledge Action in Honor of World AIDS Day 8:01 a.m. Nov. 25, 2013 - PR Newswire
ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy 8:00 a.m. Nov. 25, 2013 - PR Newswire
European Patent Office Issues Decision Regarding Universal Display's Organometallic Iridium Patent 9:01 a.m. Nov. 22, 2013 - BusinessWire
Sixth Annual Biotech Showcase(TM) Returns to San Francisco January 13-15 6:51 p.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Merck Consumer Health Turnaround on Track 4:00 a.m. Nov. 21, 2013 - BusinessWire
Critical Alerts For Netflix, Salesforce.com, Goldman Sachs, Merck, and Valero Energy Released By InvestorsObserver 9:31 a.m. Nov. 19, 2013 - PR Newswire
Merck for Mothers Working to End the Tragedy of Women in America Dying in Childbirth and Pregnancy 8:30 a.m. Nov. 19, 2013 - PR Newswire
Additional Interim Data for Merck's Investigational Anti-PD-1 Immunotherapy, MK-3475, Shows Estimated Overall Survival Rate of 81 Percent at One Year in Patients with Advanced Melanoma 12:00 p.m. Nov. 18, 2013 - BusinessWire
Merck Partners With TRUSTe to Become Certified Under APEC Cross Border Privacy Rules 9:00 a.m. Nov. 18, 2013 - Marketwire
Merck's New Drug Application for an Investigational Intravenous (IV) Formulation of NOXAFIL(R) (posaconazole) Receives FDA Priority Review 8:30 a.m. Nov. 18, 2013 - BusinessWire
RedHill Biopharma Announces Positive Scientific Advice Meeting and European Marketing Application Strategy for RHB-103 (Migraine) 8:00 a.m. Nov. 18, 2013 - GlobeNewswire
Interim Data to Be Presented for MK-3475, Merck's Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma 5:00 p.m. Nov. 15, 2013 - BusinessWire
Akorn Acquires Three Branded Ophthalmic Products from Merck 9:00 a.m. Nov. 15, 2013 - BusinessWire
Merck Strengthens its Presence in China with New Pharmaceutical Manufacturing Facility 2:00 a.m. Nov. 15, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Federal Realty Boosts Outlook with Q3 Gains

Numbers That Matter: Solid Q3 Performance Federal Realty Investment Trust's (NYSE: FRT) latest numbers paint a rosy picture—fading the gloom and doom for the moment. The steady climb from $0.69 to $0.74 in diluted EPS from last year is one thing, but it’s the 5.6% boost in Nareit-defined and Core funds from operations per diluted share that's catching eyes, now...

Cboe's Third Quarter Packs a Punch with Strong Gains

Making Waves in the Market There's no sugar-coating it—Cboe Global Markets has had a hell of a third quarter in 2026. With their diluted EPS climbing to a record $4.08, a 43% jump from last year, it's no surprise their stock ticker, CBOE, is catching some eyes. Adjusted diluted EPS also made a splash, soaring 36% to $3.63 compared to 2025 figures. Their strategic moves...

Co-op Giants Earn $309B: Key Players Spotlighted

Co-ops Punch Above Their Weight Forget the tired stereotypes about co-ops as small-time players. The NCB Co-op 100® Report lands like a punch with a staggering revelation: $309 billion in revenue for 2025. That's no small potatoes, and it shows these cooperatives, sprinkled across agriculture, finance, and beyond, are no shy creatures—they're major contenders in...

FuelCell's Legal Storm Over Misleading Disclosures

The Hard Sell on FuelCell's Promises FuelCell Energy, folks. If you've been anywhere near the market scene, you know their tale: promising clean energy with a side of misery for investors. Right now, the company finds itself in hot water over some murky disclosures about its business prowess—or lack thereof. A class action suit is brewing, and anyone with money tied up...

Hehe Culture's Timeless Wisdom Explored at Forum

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

College Towns Spark Entrepreneurial Booms Across US

Entrepreneurial Sparks Fly in Unlikely Places Turns out, it's not just the Silicon Valleys of the world creating startups—sometimes it's the coffee-driven college town where innovation quietly roots itself. GoDaddy's inaugural list of America's Most Entrepreneurial College Towns decimates the old idea that only big cities can be entrepreneurial havens. Instead, eight...

BAIC FOTON Eyes Africa for Bold Expansion Moves

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

Serena's Heart Necklaces: Tennis's Luckiest Jewelry?

You ever thought a piece of jewelry could win a game? Well, that's the buzz stirring in tennis circles these days. The iconic diamond giant, A Diamond Is Forever, dove into the gem-studded histories of some legendary players to crack open the mystery of luckiest jewelry on the court. It turns out Serena Williams takes the cake—with her heart necklaces scoring the...

Kanazawa's Winter Crab Course Brings Flavor to Life

An Unexpected Dance of Flavors Nestled in Kanazawa’s Nishi Chaya District, Canisienne Kanazawa isn’t just another eatery—it’s an engulfing dive into the world of winter crab extravagance. Picture yourself at an intimate, eight-seat counter, where chefs transform live crabs into culinary masterpieces right before your eyes. From early November to the end of...

Aemetis Faces Class Action Over Wage Violation Claims

California's Alert: Labor Code Violations Under Scrutiny Allegations like these can shake things up pretty quick, especially when you're dealing with harsh financial climates. Aemetis Advanced Fuel Keyes, Inc. is in hot water yet again—this time, they're being called out for allegedly messing up the wage game for their workers. That's right, a class action lawsuit filed...